1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 12 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Paroxetine in major depressionJureidini, J.; Tonkin, A.
2009Associations between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with TamoxifenSchroth, W.; Goetz, M.; Hamann, U.; Fasching, P.; Schmidt, M.; Winter, S.; Fritz, P.; Simon, W.; Suman, V.; Ames, M.; Safgren, S.; Kuffel, M.; Ulmer, H.; Bolander, J.; Strick, R.; Beckmann, M.; Koelbl, H.; Weinshilboum, R.; Ingle, J.; Eichelbaum, M.; et al.
1999Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adultsTaverner, D.; Bickford, L.; Shakib, S.; Tonkin, A.
2012Antidepressant-like effects of ecstasy in subjects with a predisposition to depressionMajumder, I.; White, J.; Irvine, R.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
2010Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyRibaudo, H.; Liu, H.; Schwab, M.; Schaeffeler, E.; Eichelbaum, M.; Motsinger-Reif, A.; Ritchie, M.; Zanger, U.; Acosta, E.; Morse, G.; Gulick, R.; Robbins, G.; Clifford, D.; Haas, D.
2005The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
2008Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjectsLa Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.
2005Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Darke, S.; Ross, J.; Teesson, M.; Ali, R.; Cooke, R.; Ritter, A.; Lynskey, M.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.

Discover